Research output: Contribution to journal › Article › peer-review
Studying polymorphic variants of the NAT2 gene (NAT2*5 and NAT2*7) in Nenets populations of Northern Siberia. / Tiis, Roza Pavlovna; Osipova, Ludmila Pavlovna; Lichman, Daria Veniaminovna et al.
In: BMC Genetics, Vol. 21, No. Suppl 1, 115, 22.10.2020, p. 115.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Studying polymorphic variants of the NAT2 gene (NAT2*5 and NAT2*7) in Nenets populations of Northern Siberia
AU - Tiis, Roza Pavlovna
AU - Osipova, Ludmila Pavlovna
AU - Lichman, Daria Veniaminovna
AU - Voronina, Elena Nikolaevna
AU - Filipenko, Maxim Leonidovich
N1 - Publisher Copyright: © 2020, The Author(s). Copyright: Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/10/22
Y1 - 2020/10/22
N2 - Background: N-acetyltransferase 2 plays a crucial role in the metabolism of a wide range of xenobiotics, including many drugs, carcinogens, and other chemicals in the human environment. The article presents for the first time data on the frequency of two important “slow” variants of NAT2 gene (NAT2*5, rs1801280 and NAT2*7, rs1799931), which significantly affect the rate of xenobiotics acetylation, among representatives of indigenous populations of Forest and Tundra Nenets in Northern Siberia. The aim of this study was to identify the frequencies of these variants and compare them with frequencies in other ethnic populations. Results: NAT2*5 (T341C) genotyping revealed frequencies of 28,0% and 38,6% for Tundra and Forest Nenets, respectively. The frequencies of NAT2*7 (G857A) variant were 9,8% and 8,2% for Tundra and Forest Nenets, respectively. Polymorphic variants frequencies for Nenets are intermediate between those in populations of Europeans and Asians. These results can probably be explained by the presence of both European and Asian components in Nenets gene pools. Conclusions: The results of this study expand the knowledge of NAT2 polymorphism in world populations. These data may also help assess the genetic predisposition of Nenets to multifactorial diseases associated with polymorphism in the NAT2 gene and, in general, contribute to the development of personalized medicine in reference to native people of Siberia.
AB - Background: N-acetyltransferase 2 plays a crucial role in the metabolism of a wide range of xenobiotics, including many drugs, carcinogens, and other chemicals in the human environment. The article presents for the first time data on the frequency of two important “slow” variants of NAT2 gene (NAT2*5, rs1801280 and NAT2*7, rs1799931), which significantly affect the rate of xenobiotics acetylation, among representatives of indigenous populations of Forest and Tundra Nenets in Northern Siberia. The aim of this study was to identify the frequencies of these variants and compare them with frequencies in other ethnic populations. Results: NAT2*5 (T341C) genotyping revealed frequencies of 28,0% and 38,6% for Tundra and Forest Nenets, respectively. The frequencies of NAT2*7 (G857A) variant were 9,8% and 8,2% for Tundra and Forest Nenets, respectively. Polymorphic variants frequencies for Nenets are intermediate between those in populations of Europeans and Asians. These results can probably be explained by the presence of both European and Asian components in Nenets gene pools. Conclusions: The results of this study expand the knowledge of NAT2 polymorphism in world populations. These data may also help assess the genetic predisposition of Nenets to multifactorial diseases associated with polymorphism in the NAT2 gene and, in general, contribute to the development of personalized medicine in reference to native people of Siberia.
KW - Forest and Tundra Nenets
KW - NAT2 gene
KW - NAT25, rs1801280
KW - NAT27, rs1799931
KW - Northern Siberia
KW - Xenobiotics
KW - BLADDER-CANCER
KW - GSTM1
KW - ACETYLATION
KW - GENOTYPE
KW - SUSCEPTIBILITY
KW - NAT25
KW - RISK
KW - NAT27
KW - DRUG-METABOLIZING-ENZYMES
KW - LUNG-CANCER
KW - ARYLAMINE N-ACETYLTRANSFERASES
KW - N-ACETYLTRANSFERASE-2
KW - rs1799931
KW - rs1801280
UR - http://www.scopus.com/inward/record.url?scp=85093827691&partnerID=8YFLogxK
U2 - 10.1186/s12863-020-00909-4
DO - 10.1186/s12863-020-00909-4
M3 - Article
C2 - 33092525
AN - SCOPUS:85093827691
VL - 21
SP - 115
JO - BMC Genetics
JF - BMC Genetics
SN - 1471-2156
IS - Suppl 1
M1 - 115
ER -
ID: 25863984